117 related articles for article (PubMed ID: 38186020)
1. FEATURES OF COL1A1 EXPRESSION IN BREAST CANCER TISSUE OF YOUNG PATIENTS.
Chekhun V; Mushii O; Zadvornyi T; Borikun T; Martyniuk О; Kashuba E; Kryzhanivska A; Andriiv A; Diakiv I; Lukianova N
Exp Oncol; 2023 Dec; 45(3):351-363. PubMed ID: 38186020
[TBL] [Abstract][Full Text] [Related]
2. PATTERN OF MMP2 AND MMP9 EXPRESSION DEPENDS ON BREAST CANCER PATIENTS' AGE.
Lukianova N; Mushii O; Borikun T; Zadvornyi T; Bazas V; Krotevych M; Sivak L; Lyalkin S; Martynyuk О; Hrybach S; Chekhun V
Exp Oncol; 2023 Jun; 45(1):17-27. PubMed ID: 37417285
[TBL] [Abstract][Full Text] [Related]
3. FEATURES OF BREAST CANCER IN PATIENTS OF YOUNG AGE: SEARCH FOR DIAGNOSIS OPTIMIZATION AND PERSONALIZED TREATMENT.
Chekhun V; Martynyuk О; Lukianova Y; Mushii O; Zadvornyi T; Lukianova N
Exp Oncol; 2023 Oct; 45(2):139-150. PubMed ID: 37824778
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
5. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
[TBL] [Abstract][Full Text] [Related]
6. Identification of Prognosis-Related Genes in Bladder Cancer Microenvironment across TCGA Database.
Zhao X; Tang Y; Ren H; Lei Y
Biomed Res Int; 2020; 2020():9143695. PubMed ID: 33204728
[TBL] [Abstract][Full Text] [Related]
7. Development of an algorithm for biomedical image analysis of the spatial organization of collagen in breast cancer tissue of patients with different clinical status.
Lukianova N; Mushii O; Zadvornyi T; Chekhun V
FEBS Open Bio; 2024 Apr; 14(4):675-686. PubMed ID: 38382946
[TBL] [Abstract][Full Text] [Related]
8. Young age at diagnosis is associated with worse prognosis in the Luminal A breast cancer subtype: a retrospective institutional cohort study.
Liu Z; Sahli Z; Wang Y; Wolff AC; Cope LM; Umbricht CB
Breast Cancer Res Treat; 2018 Dec; 172(3):689-702. PubMed ID: 30225619
[TBL] [Abstract][Full Text] [Related]
9. COX-2 modulates mammary tumor progression in response to collagen density.
Esbona K; Inman D; Saha S; Jeffery J; Schedin P; Wilke L; Keely P
Breast Cancer Res; 2016 Mar; 18(1):35. PubMed ID: 27000374
[TBL] [Abstract][Full Text] [Related]
10. Collagen fiber features and COL1A1: are they associated with elastic parameters in breast lesions, and can COL1A1 predict axillary lymph node metastasis?
Jiang Y; Wang B; Li JK; Li SY; Niu RL; Fu NQ; Zheng JJ; Liu G; Wang ZL
BMC Cancer; 2022 Sep; 22(1):1004. PubMed ID: 36131254
[TBL] [Abstract][Full Text] [Related]
11. A panel of 8-lncRNA predicts prognosis of breast cancer patients and migration of breast cancer cells.
Zhu L; Cui K; Weng L; Yu P; Du Y; Zhang T; Liu H; Li B; Ma W
PLoS One; 2021; 16(6):e0249174. PubMed ID: 34086679
[TBL] [Abstract][Full Text] [Related]
12. [Effect of high expression of type Ⅰ collagen α1 chain protein on the prognosis of triple negative breast cancer].
Li FF; Fan JJ; Ma BL
Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):122-126. PubMed ID: 32135646
[No Abstract] [Full Text] [Related]
13. Collagen 1A1 (COL1A1) promotes metastasis of breast cancer and is a potential therapeutic target.
Liu J; Shen JX; Wu HT; Li XL; Wen XF; Du CW; Zhang GJ
Discov Med; 2018 May; 25(139):211-223. PubMed ID: 29906404
[TBL] [Abstract][Full Text] [Related]
14. High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes.
Riaz M; Sieuwerts AM; Look MP; Timmermans MA; Smid M; Foekens JA; Martens JW
Breast Cancer Res; 2012 Sep; 14(5):R123. PubMed ID: 22967435
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of PIK3CA mutations and their association with hormone receptor expression in breast cancer: a meta-analysis.
Pang B; Cheng S; Sun SP; An C; Liu ZY; Feng X; Liu GJ
Sci Rep; 2014 Sep; 4():6255. PubMed ID: 25176561
[TBL] [Abstract][Full Text] [Related]
16. Clinical association of progesterone receptor isoform A with breast cancer metastasis consistent with its unique mechanistic role in preclinical models.
Rosati R; Oppat K; Huang Y; Kim S; Ratnam M
BMC Cancer; 2020 Jun; 20(1):512. PubMed ID: 32493230
[TBL] [Abstract][Full Text] [Related]
17. Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients.
Román-Pérez E; Casbas-Hernández P; Pirone JR; Rein J; Carey LA; Lubet RA; Mani SA; Amos KD; Troester MA
Breast Cancer Res; 2012 Mar; 14(2):R51. PubMed ID: 22429463
[TBL] [Abstract][Full Text] [Related]
18. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.
Al Sarakbi W; Mokbel R; Salhab M; Jiang WG; Reed MJ; Mokbel K
Anticancer Res; 2006; 26(6C):4985-90. PubMed ID: 17214375
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral expression of CCR3 in breast cancer is associated with improved relapse-free survival in luminal-like disease.
Gong DH; Fan L; Chen HY; Ding KF; Yu KD
Oncotarget; 2016 May; 7(19):28570-8. PubMed ID: 27086913
[TBL] [Abstract][Full Text] [Related]
20. Prolyl-4-hydroxylase α subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition.
Xiong G; Deng L; Zhu J; Rychahou PG; Xu R
BMC Cancer; 2014 Jan; 14():1. PubMed ID: 24383403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
